BioCentury
ARTICLE | Financial News

Neurochem raises C$32 million

June 22, 2000 7:00 AM UTC

Neurochem (St. Laurent, Quebec), which is developing treatments for amyloid-related diseases, raised C$32 million (US$21.8 million) in a Canadian IPO through the sale of 3.9 million shares at C$8.25. ...